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ABSTRACT 
A second derivative spectrophotometric method have been developed for 
the identif ication of tetracycline (TC), chlortetracycline (CTC)，doxycycline 
(DTC), oxytetracycline (OTC) and minocycline (MTC) ; and quantitative 
determination of TCs and related drugs. 
The direct absorption zero-order derivative spectra of tetracyclines were 
not sensitive enough to be distinguished. The second derivative spectra of the 
tetracyclines are markedly different, with the maxima and minima occurring 
at different wavelengths. The only two compounds that gave rise to similar 
spectrum were TC and OTC. However, the peak amplitude ratios of 289 and 
342 nm deflections were calculated. The ratio of the amplitude of the 289nm 
signal to the amplitude of the 342nin signal is 10.2 for TC and 20.7 for OTC. 
These values are sufficiently different to distinguish between these two 
tetracyclines. Spectra run at other concentrations proved that these amplitude 
ratios remained nearly the same at various concentrations. 
The second derivative spectrophotometric method have been developed 
for determining TC, CTC, DTC, OTC, M T C and related drugs; and for 
resolving their binary mixtures. The method permits simple, rapid, sensitive 
and direct determination of the TCs in pharmaceutical compounds without 
prior separation. In addition binary mixtures of TCs or TC and co-existing 
drugs can be resolved. 
1 
PART I INTRODUCTION 
1.1 General introduction 
Tetracyclines and their derivatives have been used extensively as 
bacteriostatic and antibiotic drugs」They act by interfering with the synthesis 
of bacterial protein. Their action is bacteriostatic. They are effective against 
a wide range of micro-organisms including Gram-positive and Gram-negative 
bacteria, rickettsiae, mycoplasmata, chlamydiae，and protozoa such as species 
of Plasmodium. Tubercle bacilli, fungi, and viruses are resistant. Resistance 
to tetracycline develops relatively slowly in susceptible organisms, but when 
it occurs there is often complete cross-resistance among all the members of 
the group. The tetracyclines are widely used in general practice, mainly for 
the treatment of infections of the chest and soft tissues, and for superficial 
infections of acne vulgaris and acne rosacea. More specialised uses are 
concerned with the treatment of organisms other than common bacteria, for 
example brucellosis, psittacosis, lymphogranuloma venereum, Q fever, primary 
atypical pneumonia, typhus, and malaria. 
A l l the tetracyclines are effective against the susceptible organisms 
indicated above, but tetracycline is the drug of choice in infections of the 
central nervous system and like oxytetracycline, is preferred to 
chlortetracycline in the treatment of urinary-tract infections, especially when 
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they are caused by Klebsiella species and Escherichia coli. 
The human body eliminates 30-60% of the initial administered amount of 
the unchanged tetracyclines through the urine in the first 24 hour.，and their 
maximum levels in serum are approximately 3-8 fig/ml. 
Fig. 1 shows the structures of tetracycline and their derivatives, they have 
very similar structures. Normal zero-order absorption spectra cannot 
distinguish these tetracyclines. The proposed method provides a simple, fast, 
sensitive, precise and accurate way to identify and assay of these drugs in the 
pharmaceutical preparations. The co-existing drugs can also be 
simultaneously determined by the proposed method without prior separation. 
3、 
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Fig. 1. Structures of (a) tetracycline, (b) chlortetracycline, (c) doxycycline, (d) 
oxytetracycline and (e) minocycline. 
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1.2 A brief review of the derivative absorption spectrophotometry 
Derivative spectrophotometry is an analytical technique of great util ity for 
extracting both qualitative and quantitative information from spectra 
composed of unresolved bands.^ In recent years, the introduction of 
electronic differentiation by a micro-computer interfaced with the 
spectrophotometer makes possible the plotting of the first, second or higher 
order derivatives of a spectrum with respect to wavelength. 
The use of derivative spectrometry is not restricted to special cases, but 
may be of advantage whenever quantitative study of the normal spectra is 
difficult.^ Its disadvantage is that the differentiation degrades the signal-to-
noise ratio, so that some form of smoothing is required in conjunction with 
the differentiation. 
For a single-peak spectrum, the first-derivative is a plot of the gradient 
d A / d 入 of the absorption envelope vs. wavelength and features a maximum, 
and a minimum; the vertical distance between these is the amplitude, which 
is proportional to the analyte concentration; theoretically, dA/dA is zero at 
入 max for the band in the normal spectrum. The second-derivative spectrum, 
2 / 2 • d A /dA vs.入，has two maxima with a minimum between them, at 入max of 
the normal absorption band. In principle, both peak-heights (measured from 
d^A/d 入2 = 0) are proportional to the analyte concentration but the amplitude 
can also be measured by the so-called tangent method, in which a tangent is 
drawn to the maxima and the amplitude is measured vertically from the 
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tangent to the minimum. 
The differentiation discriminates against broad bands, emphasizing sharper 
features to an extent that increases with increasing derivative order, because 
the amplitude D^ of the nth derivative is related to the nth power of the 
inverse of the band-width, w, of the normal spectrum: 
D n “ l / W ) n 
Thus, for two bands A and B of equal absorbance but different in width, the 
derivative amplitude of the sharper band (A, for example) is greater than that 
of the broader band(B) by a factor that increases with increasing derivative 
order : 
Dn’A/Dn,B ^ 
For this reason, the use of derivative spectra can increase the detection 
sensitivity of minor spectral features/ 
For quantitative analysis, if Beer's law is obeyed for the normal spectrum, 
the following equation can be obtained: 
= l c ( d V d : ) 
where A = absorbance; e = molar absorptivity; 1 = cell path-length; and c 
=concent ra t ion of the analyte. This forms the basis for analytical 
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determinations. 
Essentially, in the derivative spectra the ability to detect and to measure 
minor spectral features is considerably enhanced. This enhancement of 
characteristic spectral detail can distinguish very similar spectra and follow 
subtle changes in a spectrum. Moreover, it can be of use in quantitative 
analysis when it is desired to measure the concentration of an analyte whose 
peak is obscured by a larger overlapping peak due to something else in the 
sample. Let us arbitrarily consider the case in which the interfering peak has 
a height and width twice that of the analyte peak, as shown in Fig. 2. Let us 
normalize the height of the analyte band alone (upper left) to 1.0. We might 
try to neglect the interfering peak altogether and simply measure the total 
intensity (or absorbance) at the analyte maximum. The yield of a reading of 
1.9 units in this example is clearly an unsatisfactory approximation. Or we 
could try the tangential baseline technique to compensate for the presence of 
the interfering band. Actually in this particular case we cannot even draw a 
unique tangent, but if we make a reasonable guess, our reading of 0.4 units 
is far too low. Now referring to the derivative spectra in the bottom half of 
Fig. 2, we can take as the measurement of the analyte intensity, the vertical 
distance between the adjacent maximum and minimum of the first derivative. 
In the presence of the interfering band, this measurement is reduced by only 
12%，a much smaller effect than for the nonderivative data. More important， 
the effect of changes in the intensity of the interfering band is correspondingly 
reduced. As might be expected, the advantage of the derivative measurement 
depends strongly on the relative width of the two bands. I f the interfering 
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band is at least a factor of two broader than the analyte band, it will usually 
be advantageous to make the measurement on the derivative spectra. 
8， 




- j • I • 一 • I \ • ” • “ ‘ “ ‘ 1 
Normal / \ \ 0.4 
Spectra / "一 
A I T / i l 
Analyte Band Alone With Interfering Band 
First 
Derivatives 
/ r r f \ 
i V 丨 
\ 0-88 
U — L 
Analyte Band Alone Wrth Interfering Band 
Fig. 2. First derivative for quantitative measurement of intensity of a small 
band obscured by a broader overlapping band. 
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The above comments are based only on a consideration of the systematic 
errors; we must, of course, also consider the effect of random errors. Usually, 
the process of differentiation degrades the signal-to-noise ratio; thus, random 
measurement errors may be aggravated in the derivative mode. The extent 
of signal-to-noise ratio degradation depends upon a host of experimental 
variables, but a factor of two for every successive order of differentiation is 
commonly observed in practice. 
A variety of different experimental techniques have been used to obtain 
derivative spectra. I f the spectrum has been recorded digitally or is otherwise 
available in computer-readable form, then the differentiation can be done 
numerically, for example, by means of the techniques popularized by Savitsky 
and Golay.6 Alternatively, the derivative spectra may be recorded directly in 
real time, either by wavelength modulation or by obtaining the time derivative 
of the spectrum scanned at a constant rate. In the later case, a rather simple 
electronic differentiator can be used; for which many suitable circuits have 
been published. This approach is based on the idea that i f the wavelength 
scan rate, dA/dt, is constant, then the derivative of intensity I with respect 
to wavelength, dl/dA, is proportional to the derivative of intensity with respect 
to time, dl/dt，which is measured by means of an electronic differentiator: 
d l d l /d t 
d\ dA/dt 
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I f the wavelength of measurement is modulated, with a modulation 
interval which is small compared with the spectral band width, then the 
amplitude of the resulting intensity modulation wil l be proportional to the 
slope of the spectrum within the modulation interval and thus to the first 
derivative of the spectrum in this region. 
The experimental techniques used to produce wavelength modulation are: 
- Vibrat ion or oscillation of the slits, mirror, grating, or prism of the 
monochromator 
- Insertion of an oscillating or rotating refractor plate in the light 
beam inside the monochromator 
- Oscillation (tilting) of an interference filter 
- Oscillation of a Fabry-Perot interferometer 
- Use of a rotating half-sector or vibrating mirror to time-share light 
of two different wavelengths provided by two gratings or two exit 
(or entrance) slits 
- Modulation of the electron beam scan pattern in a vidicon or 
image-dissector photomultiplier spectrometer. 
Several authors have compared the relative advantages of these different 
approaches to obtaining derivative spectra?’®. In general, it is safe to say that 
electronic differentiation offers simplicity and low cost, but suffers from the 
inability to obtain derivatives at fixed wavelengths and is susceptible to signal-
to-noise degradation caused by purely temporal changes in spectral intensity 
not accompanied by genuine changes in wavelength dependence. Wavelength 
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modulation generally provides superior signal-to-noise ratio in absorption 
spectrometry or in any spectral measurement in which a time dependent 
background signal is likely to be encountered, e.g., in flame, furnace, or 
plasma emission spectrometry. 
Several commercial spectrometers capable of recording derivative spectra 
are now available, Some models of the newer UV-visible absorption 
spectrophotometers have a switch-selectable derivative range; these are mostly 
based on electronic differentiation with operational amplifier circuits. A n 
outboard electronic derivative attachment is also available. Dual-wavelength 
spectrophotometers, such as those made by Perkin-Elmer and the American 
Instrument Co., can obtain first derivative spectra by wavelength modulation. 
A wavelength modulation absorption spectrometer designed to measure only 
second derivative spectra is made by Lear Siegler, Inc. This instrument has 
heated long-pass cells for gas analysis as well as a conventional cuvette holder 
for solution work. 
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PART n I D E N T I F I C A T I O N O F 
TETRACYCLINES 
2.1 Introduction 
Several common techniques for the characterization and identification of 
tetracyclines have been reported in the literature. These techniques include 
the simple colour tests and chromatography p r o c e d u r e s ^ ' U l t r a v i o l e t 
absorption (UV) spectra are valuable in the characterization of unknown 
drugs because of its simplicity and relatively low cost^^. However structurally 
related compounds, such as tetracyclines having absorption maxima at or near 
. the same wavelengths wil l make the identification not so apparent. 
The application of derivative spectrometry offers enhancement of 
qualitative features and therefore greatly increase the fingerprinting util ity of 
U V spectrophotometry for the specific identification of organic compounds 
14,15，16. rp^e application of derivative spectrometry to U V spectrometry was 
first described in 1 9 5 3 L a t e r , information about the application of the 
technique to hypothetical situations and possible systematic and random errors 
was presentedi8’i9. Various methods for the generation of derivative spectra 
have been reviewed^® and the modified derivative functions that result from 
obtaining a derivative spectrum by electronic means have been reported^\ 
Recently ultraviolet-visible derivative spectrophotometry has begun to see 
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wider application as a valuable qualitative method^^'^^'^'^. In pharmaceutical 
analysis, the application of derivative techniques for qualitative and 
quantitative purposes was first proposed in The use of second 
derivative U V spectrophotometry in the identification of tetracycline (TC)， 
chlortetracycline (CTC), doxycycline (DTC), oxytetracycline (OTC) and 
minocycline (MTC) wi l l be described. 
2.2 Experimental 
2.2.1 Reagents 
Tetracycline hydrochloride, chortetracycline hydrochloride, doxycycline 
hydrochloride, oxytetracycline hydrochloride and minocycline hydrochloride, 
(all Sigma) 
2.2.2 Apparatus 
Spectral data were recorded with a Hitachi, Model U-2000 
spectrophotometer using quartz cells with 1-cm path length. 
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2.2.3 Procedure 
A l l scans were made in O.IM hydrochloric acid solution. Concentrations 
of the tetracyclines were approximately 8 mg r"*. 
(i) Samples were prepared in 25 ml volumetric flasks to contain 0.1-
12 m g ei ther one of T C , CTC，DTC，OTC or M T C . 0.1 M H C l 
was added to the mark. 
(ii) The absorption spectra of the samples were recorded between 200 
and 420 nm at a scan rate of 200 nm/min with medium response. 
The scale absorbance was set at 0-2 absorbance unit. Second 
derivative spectra were obtained from the build-in micro-computer 
and the derivative sensitivity is set at 2. 
(i i i) The positions of the maxima and minima of TC, CTC, DTC, OTC 
and M T C were measured. The peak to peak amplitudes D289276 
and D342，334 were measured and their ratios were calculated for TC 
and OTC. 
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2.3 RESULTS A N D DISCUSSION 
2.3.1 Methods to differentiate the TC and OTC 
The second derivative spectra of TC and OTC are similar, with the 
maxima and minima occurring at nearly the same wavelengths (Table 1). 
Thus using the positions of the extremes (maxima, minima) one can not 
differentiate these two drugs. However, the peak to peak ratios provide 
sufficient information to distinguish between these two TCs. The peak to peak 
ratios are shown in Table 2. 
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Table 1. Zero- and second-derivative U V spectra characteristics of TC, 
C T C , DTC，〇TC and M T C . 
Wavelength (nm) 
Compound — 
Zero-order Spectrum Second-order Derivative 
Spectrum 
T C 356.0，269.5, 218.5 367.5(m)，342.5, 334.5(m) 
325.0, 315.5(m), 289.0， 
276.5(m) 
CTC 368.5, 268.0, 230.0 375.5(m), 348.5，338.0(m), 
328.0, 319.0(m)，295.0， 
277.0(m)，262.5 
D T C 346.0，269.0，(218.5) 365.0(m), 355.0, 346.5(m), 
323.5, 315.5(m), 290.0， 
271.5 
OTC 354.0，269.0，217.0 365.5(m), 341.0, 333.5(m), 
324.0, 314.5(m), 288.0， 
276.0(m) 
M T C 354.0，265.5，222.0 370.0(m)，364.5, 357.0(m), 
343.0，339.0(m)，327.5， 
320.0(m), 297.0, 291.5(m), 
284.0，273.5(m) 
氺wavelength quoted are the maxima. Wavelengths denoted 
with a subscript m correspond to the minima. Shoulders are 
given in parentheses. 
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Table 2. Peak to peak ratio of TC and OTC at different wavelengths. 
peak to peak ratio TC OTC 
^232.0-220.5 
9. 6 10.3 
^324.5-315.0 
^289.0-276.0 





The ratio of D289.276 to D342.334 is quite a different between TC and OTC, 
and it is selected for the identification of TC and OTC. The signal D289.276 
was calculated by measuring the peak amplitude between the maximum at 289 
nm and the minimum at 276 nm. Similarly, the signal D342.334 was calculated 
by measuring the peak amplitude between the maximum at 342 nm and the 
minimum at 334 nm. The ratio of the amplitude of D289.276 to the amplitude 
of the D342.334 is 10.2 for TC and 20.7 for OTC. These values are sufficiently 
different to distinguish between these two TCs. 
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2.3.2 Effect of concentration 
Five different concentrations of TC and OTC were measured, and the 
ratio of D289.276 to D342.334 were calculated. The results are collected in Table 
3. I t was observed that these amplitude ratios remained nearly the same at 
all concentrations. The average peak to peak ratio is 10.2 for TC and 20.7 
for OTC. The standard deviation is 0.51 for TC and 0.39 for OTC. 
Table 3. Results of the peak to peak ratio of TC and OTC at different 
concentrations. 
= o f D289-276/ ^onc. of D ^ 隨 
TC (ppm) D342-334 OTC D342-334 
2 9.7 2 20.7 
4 10.9 4 20.8 
16 10.8 16 21.2 
32 9.8 32 20.6 
48 10.0 48 20.0 
Average 10.2 20.7 
Standard 0.51 0.39 
deviation 
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2.3.3 Selection of derivative sensitivity 
In derivative calculation, the neighbouring spectral data is required to 
determine a derivative value of the spectrum. The SENSITIVITY defines 
the neighbouring spectral data range to be included in derivative calculation. 
Increasing the SENSITIVITY value, the spectral plot is smooth but the fine 
peaks become dull. 
From the second derivative spectra with different SENSITIVITY (Fig. 3). 
Only SENS 2 and SENS 3 spectra show a fine and smooth graph. Since finer 
structure is better for qualitative work, SENS 2 is selected. 
2.4 Conclusion 
When the normal absorption zero-order derivative spectra of tetracyclines 
were run, only the CTC showed a quite different maxima, and they were not 
sensitive enough to distinguish among TC, DTC, OTC and MTC. Their 
absorption maxima are 356.0，269.5 and 218.5nm for TC; 368.5, 268.0 and 
230.0nm for CTC; 346.0, 269.0nm for DTC; 354.0，269.0 and 217.0nm for 
OTC; and 354.0, 265.5 and 222.0nm for MTC (Fig. 4). 
The second derivative (d^A/d ^)of a spectral line is inverted with respect 
to the zero-order spectrum and exhibits a strong minimum at a point of 
maximum negative curvature of the absorption curve. Therefore, the original 
20 
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(zero-order) peak is considerably sharpened in the second derivative 
spectrum which improves the resolution of overlapping bands with increased 
sensitivity. 
Fig. 5 illustrates the second derivative spectra of the tetracyclines dissolved 
in O.IM H C l . With the exception of TC and OTC, these spectra have similar 
maxima and minima. However, every spectrum shows a very significant ‘ •» 
enhancement in spectral detail over its zero-order spectrum. 
The second derivative spectra of the tetracyclines, are markedly different, 
with the maxima and minima occurring at different wavelengths. Only the 
spectra for TC and OTC show resemblance. Nevertheless the positions of 
the extremes (maxima, minima) and their peak differences permit the 
differentiation between these two drugs. The peak amplitude ratios of 289 
and 342 nm deflections were calculated. The signal at 289 nm was calculated 
by measuring the peak amplitude between the maximum at 289 and the 
minimum at 276nm (peak to peak measurement: a I). Similarly, the signal at 
342 nm was calculated by measuring the peak amplitude between the 
maximum at 342 and the minimum at 334 run. 
The ratio of the amplitude of the 289 nm signal to the amplitude of the 
342 nm signal is 10.2 for TC and 20.7 for OTC. These values are sufficiently 
different to distinguish between these two tetracyclines. 
Spectra run at other concentrations indicated that these amplitude ratios 
24 
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remained nearly the same (standard deviation is 0.51 for TC and 0.39 for 
OTC in 5 different concentration measurements). 
These results indicate that the compounds studied exhibit characteristic 
second-order derivative spectra which may be useful for identification 
purposes. Chemical derivatization or addition of complexing agents is not 
required to enhance the specificity and U V characteristics of the tetracyclines 
investigated. Derivative spectroscopy, in this instance, has proven to be 
successful in differentiating compounds which have similar zero-order U V 
spectra. Furthermore, identification is possible with low concentrations (2mg 
I'l)，and applicable to the pharmaceutical preparations. 
Derivative spectroscopy provides a relatively simple and inexpensive 
approach to drug analysis. Derivative spectroscopy should find many other 
applications as more analyze become aware of its potential as a technique in 
qualitative as well as quantitative analysis. 
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P A R X m QUANTITATIVE DETERMINATION 
OF TETRACYCLINES AND RELATED 
DRUGS 
3.1 Introduction 
Tetracyclines and their derivatives (chlortetracycline, oxytetracydine, 
doxycycline, minocycline, etc.) have been employed extensively as 
bacteriostatic and antibiotic drugs. In the last few years, a number of 
methods for determining tetracyclines have been reported. For example, the 
determination of tetracyclines in pharmaceutical preparations using the 
polarographic methods with d.c., a.c. and differential-pulse polarography have 
been proposed^^'^®. Spectrophotometric methods based on the oxidation of 
tetracyclines and their derivatives with ammonium vanadate^^, sodium 
cobaltinitrite3o and sodium molybdate^^ have been proposed for determining 
several tetracyclines in pharmaceutical compounds. In both methods, the 
tetracyclines show identical analytical behaviour; therefore, the resolution of 
binary mixtures of tetracyclines cannot be achieved. 
The ability of tetracyclines to form metal ion complexes has also been 
reported and the chelation with cations has been applied extensively to the 
determination of these compounds^^'^^. 
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In general, the spectrophotometric methods proposed to determine 
tetracycline derivatives posses limited selectivity; hence methods based on 
high-performance liquid chromatography (HPLC) are the most 
1 34 35 36 37 
popular ’ ’ ， . The determination of oxytetracycline and epimer derivatives 
has been achieved by HPLC method^®. 
By using this technique, tetracyclines can be determined in the presence 
of other commonly occurring constituents in several pharmaceutical 
compounds, urine^^ and also in 
A fluorimetric method for the determination of tetracyclines in biological 
materials based on solvent extraction of mixed tetracycline-calcium 
trichloroacetate ion pair f rom aqueous solutions has been reported^。. 
A method based on derivative spectrophotometry has so far been reported 
for the determination of tetracyclines'^^. The method is based on 
measurement of the quotient of the first-order spectrum displacement effect 
induced by a change in the p H as a function of concentration, and tetracycline 
and oxytetracycline were determined in commercial capsule preparations. 
Another method has been proposed for the determination of oxytetracycline 
and doxycycline in pharmaceutical compounds, urine and honey by derivative 
spectrophotometry'^'^. The method is based on direct measurements of the 
appropriate signals in the first-derivative spectra. 
The determination of tetracyclines in pharmaceutical compounds, is 
frequently carried out. In this part, methods for determining tetracycline, 
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chlortetracydine, doxycycline, oxytetracycline and minocycline in these 
samples are proposed. The methods are based on direct measurements of the 
appropriate signals in the second-derivative spectra. In addition, the second-
derivative spectra can be used for resolving binary mixtures of TCs and 
related drugs in pharmaceutical preparations and synthetic samples. 
3.2 Experimental 
3.2.1 Sample treatment 
1. Tablets : A t least 20 tablets were weighed and grinded well. A certain 
amount of this powder representing 100 mg tetracycline was transferred 
to a 100 ml volumetric flask. About 50 ml 0.1 M HCl was added and 
shaken in an ultrasonic bath for 10 min. 
2. Capsules : The powder from at least 10 capsules was weighed and mixed. 
A portion of the powder equivalent to about 100 mg tetracycline was 
transferred to a 100 ml volumetric flask and proceeded as described under 
1. Tablets, above. 
3. Ointments : Some amount of ointment representing about 10 mg 
tetracycline was weighed and transferred to a 100 ml separatory funnel. 
About 40 ml ethyl ether was added, shaken well, and extracted with three 
25 ml portions of 0.1 M HCl. The extracts were combined and diluted to 
100 ml with the same solvent in a volumetric flask. 
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3.2.2 Derivative spectrophotometric method 
1. Apparatus : A Hitachi model U-2000 double-beam spectrophotometer 
using quartz cells with 1-cm path length was used. 
2. Reagents : A l l reagents used were of analytical reagent grade. 
(i) 0.1 M hydrochloric acid : 10.1 ml of 9.9 M hydrochloric acid was 
diluted to 1 litre with distilled water. 
(i i) 0.1 M sodium hydroxide : 50 ml 1 M standard sodium hydroxide 
was diluted to 500 ml with distilled water. 
(i i i) Stock solutions of TCs : Stock solutions of 400 ppm were freshly 
prepared by dissolving separately 200 mg each of the TC, CTC, 
DTC, OTC and MTC in 0.1 M HCl and diluted to 500 ml in 
volumetric flasks. 
(iv) TCs standard solutions : These were freshly prepared by 
appropriate dilutions of the 400 ppm TCs stock solution with 0.1 
M HCl. 
(V) Standard solutions of other related drugs : Stock solutions of 400 
ppm were freshly prepared by dissolving separately 200 mg ascorbic 
acid, amphotericin B, lidocaine and polymyxin B sulphate in 0.1 M 
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HCl and diluted to 500 ml in volumetric flasks. 
(vi) Standard solutions of novobiocin in 0.1 M NaOH : Stock solutions 
of 400 ppm were freshly prepared by dissolving separately 200 mg 
novobiocin sodium salt in 0.1 M NaOH and diluted to 500 ml in a 
volumetric flask. 
(vii) Standard solutions of beclomethasone dipropionate in M e O H : 
Stock solutions of 400 ppm were freshly prepared by dissolving 
separately 200 mg beclomethasone dipropionate solutions in 
anhydrous M e O H and diluted to 500 ml in a volumetric flask. 
3. Procedure . 
(i) Single component of TC, CTC, DTC, OTC and MTC in 0.1 M HCl 
: T h e wavelength range was set at 400-300 nm. The calibration 
curve was separately prepared by measuring the second derivative 
absorbance value at 365.8 nm for TC, 372.4 nm for CTC, 344.8 nm 
for DTC, 361.4 nm for OTC and 361.0 nm for MTC against a blank 
solution. The standard solutions were prepared by diluting 0.1-5 ml 
400 ppm stock solution with 0.1 M HCl in 25 ml volumetric flasks 
to give 2-100 ppm standard solutions. A blank solution was 
prepared by using 0.1 M HCl. The slopes of the calibration curves 
were measured. 
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(ii) Binary mkture of TC and CTC in 0.1 M HCl : The calibration 
curve was prepared by measuring the second derivative absorbance 
value at 235.8 nm of TC and 225.8 nm of CTC in their mixture. 
The standard solutions were prepared by mixing 0.1 - 5 ml 400 
ppm stock solution of TC and 0.1 - 5 ml 400 ppm stock solution of 
CTC in various proportions in 25 ml volumetric flasks. And 0.1 M 
HC l was added to the marks. The slopes of the calibration curves 
were measured. 
(i i i) Binary mixture of TC and DTC in 0.1 M HCl : The calibration 
curve was prepared by measuring the second derivative absorbance 
value at 374.8 nm for TC and 380.2 nm for DTC in their mixture. 
The standard solutions were prepared by mixing 0 . 1 - 5 ml 400 
ppm stock solution of TC and 0.1 - 5 ml 400 ppm stock solution of 
D T C in various proportions in 25 ml volumetric flasks. And 0.1 M 
HC l was added to the marks. The slopes of the calibration curves 
were measured. 
(iv) Binary mixture of CTC and OTC in 0.1 M HCl : The calibration 
curve was prepared by measuring the second derivative absorbance 
value at 247.2 nm of CTC and 235.3 nm of OTC in their mixture. 
The standard solutions were prepared by mixing 0.1 - 5 ml 400 
ppm stock solution of CTC and 0.1 - 5 ml 400 ppm stock solution 
of OTC in various proportions in 25 ml volumetric flasks. And 0.1 
M HC l was added to the marks. The slopes of the calibration 
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curves were measured. 
( V ) Binary mixture of CTC and DTC in 0.1 M HCl - The calibration 
curve was prepared by measuring the second derivative absorbance 
value at 375.4 nm of CTC and 235.6 nm of DTC in their mixture. 
The standard solutions were prepared by mixing 0.1 - 5 ml 400 
ppm stock solution of CTC and 0.1 - 5 ml 400 ppm stock solution 
of DTC in various proportions in 25 ml volumetric flasks. 0.1 M 
HCl was added to the marks. The slopes of the calibration curves 
were measured. 
(vi) Binary mixture of DTC and OTC in 0.1 M HCl : The calibration 
curve was prepared by measuring the second derivative absorbance 
value at 334.2 nm of DTC and 375.2 nm of OTC in their mixture. 
The standard solutions were prepared by mixing 0.1 - 5 ml 400 
ppm stock solution of DTC and 0.1 - 5 ml 400 ppm stock solution 
of OTC in various proportions in 25 ml volumetric flasks. 0.1 M 
HCl was added to the marks. The slopes of the calibration curves 
were measured. 
(vii) Binary mixture of TC and novobiocin in 0.1 M NaOH : The 
calibration curve was prepared by measuring the second derivative 
absorbance value at 241.6 nm of TC and 314.4 nm of novobiocin 
in their mixture. The standard solutions were prepared by mixing 
0.1 - 5 ml 400 ppm stock solution of TC and 0.1 - 5 ml 400 ppm 
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stock solution of OTC in various proportions in 25 ml volumetric 
‘ flasks. 0.1 M NaOH was added to the marks. The slopes of the 
calibration curves were measured. 
(viii) Binary mixture of TC and amphotericin B in 0.1 M HCl : The 
calibration curve was prepared by measuring the second derivative 
absorbance value at 240.5 nm of TC and 247.5 nm of amphotericin 
B in their mixture. The standard solutions were prepared by mixing 
0.1 - 5 ml 400 ppm stock solution of TC and 0.1 - 5 ml 400 ppm 
stock solution of amphotericin B in various proportions in 25 ml 
volumetric flasks. 0.1 M HCl was added to the marks. The slopes 
of the calibration curves were measured. 
(ix) Binary mixture of TC and ascorbic acid in 0.1 M HCl : The 
calibration curve was prepared by measuring the second derivative 
absorbance value at 365.8 nm of TC and 248.2 nm of ascorbic acid 
in their mixture. The standard solutions were prepared by mixing 
0.1 - 5 ml 400 ppm stock solution of TC and 0.1 - 5 ml 400 ppm 
stock solution of ascorbic acid in various proportions in 25 ml 
volumetric flasks. 0.1 M HCl was added to the marks. The slopes 
of the calibration curves were measured. 
( X ) Binary mixture of CTC and beclomethasone dipropionate in 
methanol : The calibration curve was prepared by measuring the 
second derivative absorbance value at 377.6 nm of CTC and 283.8 
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nm of beclomethasone dipropionate in their mkture. The standard 
solutions were prepared by mixing 0.1 - 5 ml 400 ppm stock 
solution of CTC and 0.1 - 6 ml 400 ppm stock solution of 
beclomethasone dipropionate in various proportions in 25 ml 
volumetric flasks. 0.1 M HC l was added to the marks. The slopes 
of the calibration curves were measured. 
Od) Binary mixture of OTC and lidocaine in 0.1 M HCl : The 
calibration curve was prepared by measuring the second derivative 
absorbance value at 361.4 nm of OTC and 247.4 nm of lidocaine 
in their mixture. The standard solutions were prepared by mixing 
0.1 - 5 ml 400 ppm stock solution of OTC and 0.05 - 11 ml 400 
ppm stock solution of lidocaine in various proportions in 25 ml 
volumetric flasks. 0.1 M HC l was added to the marks. The slopes 
of the calibration curves were measured. 
(xii) Binary mixture of OTC and polymyxin B in 0.1 M HCl : The 
calibration curve was prepared by measuring the second derivative 
absorbance value at 361.4 nm of OTC and 224.2 nm of polymyxin 
B in their mixture. The standard solutions were prepared by mixing 
0.1 - 5 ml 400 ppm stock solution of OTC and 0.05 - 8 ml 400 ppm 
stock solution of polymyxin B in various proportions in 25 ml 
volumetric flasks. 0.1 M HC l was added to the marks. The slopes 
of the calibration curves were measured. 
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3.2.3 Counter-check by HPLC method 
The HPLC chromatograph was connected to a Beckmann 421 -A 
Controller, 110-B solvent Delivery Module System Organizer, a 163 variable 
wavelength detector and a 427 integrator. 
The HPLC column was Altex Ultrasphere - ODS.(4.6 mm x 25 cm) 
The chromatographic conditions were set as follows : 
Column temperature Ambient 
Scan rate 1.0 ml /min 
Chart speed 0.25 cm/min 
Injection volume 20 /i l 
Detector wavelength 280 nm 
Procedure : 
The mobile phase was prepared as follows : 
In 760 ml water were dissolved 5.2 g diammonium hydrogen phosphate and 
5.0 ml ethanolamine. To the solution were added 240 ml A C N and 60 ml 
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DMF. Finally the pH was adjusted to 2.5 using orthophosphoric acid. After 
fi ltration through a 0.5 f im pore size membrane filter, the mobile phase was 
ultrasonically degassed. 
The standard solution containing TC, CTC, DTC and OTC in anhydrous 
methanol was mixed with the internal standard just prior to injection. 
Calibration curves for TC, CTC, DTC and OTC were constructed with their 
corresponding peak area ratio ( ratio of TC to internal standard ) plotted 
against their concentrations. 
A 20-m1 aliquot of the sample solution was injected into the 
chromatograph. The corresponding concentrations of TC, CTC, DTC and 
OTC were deduced from the calibration curves. 
3.3 Results and discussion 
3.3.1 Method development 
The application of derivative spectrophotometry to simultaneous 
determination of binary mixtures of TCs, TC and its co-existing drugs, or 
determination of single component of TCs in pharmaceutical preparations is 
described. For the determination of binary mixtures, the second derivative 
spectra of mixtures is run at which the concentration of one drug is varied in 
the presence of a fixed concentration of the other. The absorbance value at 
the isosbestic point can be used to determine the drug that has fixed 
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concentration in the mixtures. Several isosbestic points may be present and 
can also be used for the quantitative determination. However the one with 
the greatest amplitude should be selected for highest sensitivity. 
1. Binary mixture of TC and CTC 
The absorbance maxima of TC and CTC are close together in this 
wavelength region, hence simultaneous determination by solving simultaneous 
equations for the wavelengths is difficult and gives erroneous results. In Fig. 
6a the second derivative spectra of mixtures of TC and CTC in 0.1 M HCl 
were shown. The TC concentration was kept at 8 ppm, whereas the 
concentration of CTC was varied (4-16 ppm). I t can clearly be seen that the 
CTC at various concentrations does not interfere in the determination of TC 
at the isosbestic point of 235.8 nm. 
The second derivative spectra of mixtures, where the concentration of TC 
was varied (4-16 ppm) in the presence of a fixed concentration of CTC (8 
ppm )，were shown in Fig. 6b. The isosbestic point at 225.8 nm is observed 
at which the concentration of CTC can be determined in the presence of TC. 
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Fig. 6. Second derivative spectra of mixtures : (a) TC fixed at 8 ppm and CTC 
varied f rom 4 to 16 ppm; (b) CTC fixed at 8 ppm and TC varied from 4 to 
16 ppm. 
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2. Binary mixture of TC and DTC 
The absorbance maxima of TC and DTC are close together in this 
wavelength region, hence simultaneous determination by solving simultaneous 
equations for the wavelengths is difficult and gives erroneous results. In Fig. 
7a the second derivative spectra of mixtures of TC and DTC in 0.1 M HCl 
were shown. The TC concentration was kept at 8 ppm, whereas the 
concentration of CTC was varied (4-16 ppm). The isosbestic point at 374.8 
nm can be used to determine the TC in the presence of the DTC. 
The second derivative spectra of mixtures, where the concentration of TC 
was varied (4-16 ppm) in the presence of a fixed concentration of DTC (8 
ppm )，were shown in Fig. 7b. The isosbestic point at 380.2 nm is observed 
at which the concentration of DTC can be determined in the presence of TC. 
3. Binary mixture of CTC and DTC 
The absorbance maxima of CTC and DTC are close together in this 
wavelength region, hence simultaneous determination by solving simultaneous 
equations for the wavelengths is difficult and gives erroneous results. In Fig. 
8a the second derivative spectra of mixtures of CTC and DTC in 0.1 M HCl 
were shown. The CTC concentration was kept at 8 ppm, whereas the 
concentration of DTC was varied (4-16 ppm). The isosbestic point at 375.4 
nm can be used to determine the CTC in the presence of the DTC. 
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Fig. 7. Second derivative spectra of mixtures : (a) TC fixed at 8 ppm and 
DTC varied from 4 to 16 ppm; (b) DTC fixed at 8 ppm and TC varied from 
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Fig. 8. Second derivative spectra of mixtures : (a) DTC fixed at 8 ppm and 
CTC varied from 4 to 16 ppm; (b) CTC fixed at 8 ppm and DTC varied from 
4 to 16 ppm. 
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The second derivative spectra of mixtures, where the concentration of 
CTC was varied (4-16 ppm) in the presence of a fixed concentration of DTC 
(8 ppm )，were shown in Fig. 8b. The isosbestic point at 235.6 nm is observed 
at which the concentration of DTC can be determined in the presence of 
CTC. 
4. Binary mixture of CTC and OTC 
The absorbance maxima of CTC and OTC are close together in this 
wavelength region, hence simultaneous determination by solving simultaneous 
equations for the wavelengths is difficult and gives erroneous results. In Fig. 
9a the second derivative spectra of mixtures of CTC and OTC in 0.1 M HCl 
were shown. The CTC concentration was kept at 8 ppm, whereas the 
concentration of OTC was varied (4-16 ppm). The isosbestic point at 247.2 
nm can be used to determine the CTC in the presence of the OTC. 
The second derivative spectra of mixtures, where the concentration of 
CTC was varied (4-16 ppm) in the presence of a fixed concentration of OTC 
(8 ppm ), were shown in Fig. 9b. The isosbestic point at 235.3 nm is observed 
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Fig. 9. Second derivative spectra of mixtures : (a) CTC fixed at 8 ppm and 
OTC varied from 4 to 16 ppm; (b) OTC fixed at 8 ppm and CTC varied from 
4 to 16 ppm. 
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5. Binary mixture of DTC and 〇TC 
The absorbance maxima of DTC and OTC are close together in this 
wavelength region, hence simultaneous determination by solving simultaneous 
equations for the wavelengths is difficult and gives erroneous results. In Fig. 
10a the second derivative spectra of mixtures of DTC and OTC in 0.1 M HCl 
were shown. The DTC concentration was kept at 8 ppm, whereas the 
concentration of OTC was varied (4-16 ppm). The isosbestic point at 334.2 
nm can be used to determine the DTC in the presence of the OTC. 
The second derivative spectra of mixtures, where the concentration of 
DTC was varied (4-16 ppm) in the presence of a fixed concentration of OTC 
(8 ppm )，were shown in Fig. 10b. The isosbestic point at 375.2 nm is 
observed at which the concentration of OTC can be determined in the 
presence of DTC. 
6. Binary mixture of TC and novobiocin in 0.1 M NaOH 
The second derivative spectra of mixtures of TC and novobiocin in 0.1 M 
NaOH were shown in Fig. 11a. The TC concentration was kept at 8 ppm, 
whereas the concentration of novobiocin was varied (4 _ 16 ppm). The 
isosbestic point at 241.6 nm can be used to determine the TC in the presence 
of the novobiocin. 
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Fig. 10. Second derivative spectra of mixtures : (a) DTC fixed at 8 ppm and 
OTC varied from 4 to 16 ppm; (b) OTC fixed at 8 ppm and DTC varied from 
4 to 16 ppm. 
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Fig. 11. Second derivative spectra of mixtures in 0.1 M NaOH : (a) TC fixed 
at 8 ppm and novobiocin varied from 4 to 16 ppm; (b) novobiocin fixed at 8 
ppm and TC varied from 4 to 16 ppm. 
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The second derivative spectra of mixtures, where the concentration of TC 
was varied (4-16 ppm) in the presence of a fixed concentration of novobiocin 
(8 ppm )，were shown in Fig. l i b . The isosbestic point at 314.4 nm is 
observed at which the concentration of novobiocin can be determined in the 
presence of TC. 
7. Binary mixture of TC and amphotericin B in 0.1 M HC l 
The second derivative spectra of mixtures of TC and amphotericin B in 
0.1 M HC l were shown in Fig. 12a. The TC concentration was kept at 8 ppm, 
whereas the concentration of amphotericin B was varied (4-16 ppm). The 
isosbestic point at 240.5 nm can be used to determine the TC in the presence 
of the amphotericin B. 
The second derivative spectra of mixtures, where the concentration of TC 
was varied (4 - 16 ppm) in the presence of a fixed concentration of 
amphotericin B (8 ppm )，were shown in Fig. 12b. The isosbestic point at 
247.5 nm is observed at which the concentration of amphotericin B can be 
determined in the presence of TC. 
8. Binary mixture of TC and ascorbic acid in 0.1 M HCl 
The second derivative spectra of ascorbic acid in 0.1 M HCl was shown 
in Fig. 13. The second derivative absorbance value at the wavelength above 
300 nm is zero. For the determination of TC at those wavelength in the 
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Fig. 12. Second derivative spectra of mixtures : (a) TC fixed at 8 ppm and 
amphotericin B varied from 4 to 16 ppm; (b) amphotericin B fixed at 8 ppm 
and TC varied from 4 to 16 ppm. 
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mixture wil l not be interfered by the presence of ascorbic acid. 
The wavelength at 365.8 nm is selected for the determination of TC，since 
highest absolute value of amplitude is present here. Sensitivity is greatest for 
the determination of TC in the mixture. 
The second derivative spectra of mixtures of TC and ascorbic acid in 0.1 
M HCl were shown in Fig. 14a. The ascorbic acid concentration was kept at 
8 ppm, whereas the concentration of TC was varied (4-16 ppm). The 
isosbestic point at 248.2 nm can be used to determine the ascorbic acid in the 
presence of the TC. 
9. Binary mixture of CTC and beclomethasone dipropionate in M e O H 
The second derivative spectra of beclomethasone dipropionate in MeOH 
was shown in Fig. 13. The second derivative absorbance value at the 
wavelength above 310 nm is zero. For the determination of CTC at those 
wavelengths in the mixture wil l not be interfered by the presence of 
beclomethasone dipropionate. 
The wavelength at 377.6 nm is selected for the determination of CTC， 
since highest absolute value of amplitude is present here. Sensitivity is 
greatest for the determination of CTC in the mixture. 
The second derivative spectra of mixtures of CTC and beclomethasone 
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dipropionate in M e O H were shown in Fig. 14b. The beclomethasone 
dipropionate concentration is kept at 8 ppm, whereas the concentration of 
CTC is varied (4-16 ppm). The isosbestic point at 283.8 nm can be used to 
determine the beclomethasone depropionate in presence of the CTC. 
10. Binary mixture of OTC and lidocaine in 0.1 M HCl 
The second derivative spectra of lidocaine in 0.1 M HCl was shown in Fig. 
13. The second derivative absorbance value at the wavelength above 300 nm 
is zero. For the determination of OTC at those wavelength in the mixture 
wi l l not be interfered by the presence of lidocaine. 
The wavelength at 361.4 nm is selected for the determination of OTC， 
since highest absolute value of amplitude is present here. Sensitivity is 
greatest for the determination of OTC in the mixture. 
The second derivative spectra of mixtures of OTC and lidocaine in 0.1 M 
HC l were shown in Fig. 14c. The lidocaine concentration was kept at 8 ppm, 
whereas the concentration of OTC was varied (4 - 16 ppm). The isosbestic 
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Fig. 13. (a) Zero- and (b) second order spectra of (1) amphotericin B in 0.1 
M HCl, (2) ascorbic acid in 0.1 M HCl, (3) Beclomethasone dipropionate in 
MeOH，（4) lidocaine in 0.1 M HCl, (5) novobiocin in 0.1 M NaOH and (6) 
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Fig. 14. Second derivative spectra of mixtures : (a) TC fixed at 8 ppm and 
ascorbic acid varied from 4 to 16 ppm; (b) CTC fixed at 8 ppm and 
beclomethasone dipropionate varied from 4 to 16 ppm; (c) OTC fixed at 8 
ppm and lidocaine varied from 4 to 16 ppm; (d) OTC fixed at 8 ppm and 


































































































































11. Binary mixture of OTC and polymyxin B in 0.1 M HCl 
The second derivative spectra of polymyxin B in 0.1 M HCl was shown in 
Fig. 13. The second derivative absorbance value at the wavelength above 260 
nm is zero. For the determination of OTC at those wavelength in the mixture 
wi l l not be interfered by the presence of polymyxin B. 
The wavelength at 361.4. nm is selected for the determination of OTC , 
since highest absolute value of amplitude is present here. Sensitivity is 
greatest for the determination of OTC in the mixture. 
The second derivative spectra of mixtures of OTC and polymyxin B in 0.1 
M HCl were shown in Fig. 14d. The polymyxin B concentration was kept at 
8 ppm, whereas the concentration of OTC was varied (4 - 16 ppm). The 
isosbestic point at 224.2 nm can be used to determine the polymyxin B in the 
presence of the O T C 
3.3.2 Choice of p H and solvent 
The stability of TC in solution of different p H is studied. From the result 
shown in the Table 4 , TC is more stable in acidic solution. 
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Table 4. p H effect on the stability of TC (8 ppm). 
PH After 2 hours After 4 hours 
found(ppm) % change found(ppm) % change 
2 8.06 0.75 8.12 1.5 
4 8.26 3.25 8.49 6.12 
6 8.47 5.88 8.75 9.38 
8 8.38 . 4.75 8.70 8.75 
10 8.35 4.38 8.66 8.25 
12 8.23 2.88 8.40 5.00 
The standard tetracyclines we used were the hydrochloride salt.. In order 
to reduce the complexity of the matrix, HCl was selected as the solvent for 
analysis. Novobiocin and beclomethasone dipropionate do not dissolve in the 
acidic solution, we used 0.1 M NaOH for novobiocin and MeOH for 
beclomethasone dipropionate instead of HCl as the solvent in their binary 
mixtures. 
3.3.3 Selection of SENSITIVITY of derivative 
In derivative calculation, the neighbouring spectral data is required to 
determine a derivative value of spectrum. The SENSITIVITY defines the 
neighbouring spectral data range to be included in derivative calculation. 
Increasing the SENSITIVITY value, the spectral plot is smooth but the fine 
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Fig. 15. Second derivative spectra of TC in 0.1 M HCl at different derivative 
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From the second derivative spectra with different SENS (Fig. 15)，lower 
derivative SENS value shows fine peaks, but also has lower absorbance value. 
In order to obtain a higher sensitivity of analysis, SENS 5 is selected. 
3.3.4 Choice of scan rate 
The results in Table 5 show that the scan rate does not change the 
absorbance value significantly. However, the spectra in fast scan rate is less 
smooth (Fig. 16); and in slow scan rate it is too time consuming. The scan 
rate of 200 nm/min was chosen because the time required for each run is 
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Fig. 16. Second derivative spectra of TC at different scan rate (a) 200 nm/min 
(b) 1200 nm/min. 
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Table 5. Second derivative absorbance value of 8 ppm TC at different scan 
rates. 
Scan rate (nm/min) Value of second 
derivative at 365.Omn 
2400 0.096 







3.3.5 Interference studies 
Besides the components of interest, most of the tablets, capsules and 
ointments contain other ingredients such as preservatives, dyes and flavour. 
The interference from these ingredients has been studied. 
The criterion for an interference was a signal varying ±5% from the 
expected value. Results of the interference study are shown in Table 6 . It 
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was found that the ingredients studied had no interference in the proposed 
method. 
Table 6. TC signal affected by other components in real samples. 
Ingredient Cone, of Cone, ratio Found Error(%) 
ingredient ingredient: TC 
(ppm) ‘ 
starch 15000 1875 7.65 -4.4 
sodium citrate 12000 1500 8.30 3.8 
citric acid 14000 1750 1.12 _4.8 
fumaric acid 1600 100 7.60 -5.0 
sucrose 15000 1875 7.65 -4.4 
lactose 1600 200 8.30 3.8 
magnesium 1200 150 8.35 4.4 
chloride ‘ 
ascorbic acid 1000 125 7.65 -4.4 
procaine 800 100 8.31 3.9 
(8ppm TC in each sample) 
3.3.6 Precision studies 
The precision of the proposed method was accessed, where the relative 
standard deviation for ten replicate determinations of the second derivative 
absorbance of several concentrations of standard TCs and related drugs was 
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determined and shown in the following tables. (Table 7 to 11) 
The reproducibility of the method is satisfactory. 
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Table 11. Precision test for the determination of MTC. The relative standard 
deviations for ten replicates at different concentrations were calculated. 
Cone, of Second derivative Relative standard 
TC(ppm) absorbance value deviation, % 
at 365.8nin ‘ 
4.00 0.047 0.5 
8.00 0.097 0.1 
16.00 0.195 0.2 
32.00 0.391 0.5 
48.00 0.587 0.5 
Table 8. Precision test for the determination of CTC. The relative standard 
deviations for ten replicates at different concentrations were calculated. 
Cone, of Second derivative Relative standard 
CTC(ppm) absorbance value deviation, % 
at 372.4nm ‘ 
4.00 0.032 0.7 
8.00 0.064 0.8 
16.00 0.117 0.5 
32.00 0.251 0.9 
48.00 0.372 0.8 
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Table 11. Precision test for the determination of MTC. The relative standard 
deviations for ten replicates at different concentrations were calculated. 
Cone, of Second derivative Relative standard 
DTC(ppm) absorbance value deviation, % 
at 344.8nin , 
4.00 0.026 0.6 
8.00 0.050 0.3 
16.00 0.097 0.2 
32.00 0.189 0.4 
48.00 0.281 0.3 
Table 10. Precision test for the determination of OTC. The relative standard 
deviations for ten replicates at different concentrations were calculated. 
Cone, of Second derivative Relative standard 
OTC(ppm) absorbance value deviation, % 
at 361.4nm ‘ 
4.00 0.041 0.7 
8.00 0.085 0.6 
16.00 0.163 0.5 
32.00 0.341 0.6 
48.00 0.521 0.4 
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Table 11. Precision test for the determination of MTC. The relative standard 
deviations for ten replicates at different concentrations were calculated. 
Cone, of Second derivative Relative standard 
MTC(ppm) absorbance value deviation, % 
at 361.0mn ’ 
4.00 0.034 1.1 
8.00 0.065 0.8 
16.00 0.135 0.5 
32.00 0.265 0.7 
48.00 0.393 0.5 
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3.3.7 Construction of the calibration curve 
Typical calibration graphs of TC, CTC, DTC, OTC and MTC were 
illustrated in Fig. 17 to Fig. 21, and the relevant data for these graphs were ‘ 
shown in Table 12 to Table 16. 
The results of the statistical analysis of the determination of TCs and the 













































































































































































































































































































































































































































































































































































































































































































































































































































Table 13. Data for the calibration graph for the determination of CTC in 
O.IM HCl at 372.4 nm. 
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Table 13. Data for the calibration graph for the determination of CTC in 
O.IM HCl at 372.4 nm. 
conc. of OTC (ppm) second derivative 
absorbance value 
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Table 17. Summary of results on the determination of TCs and related drugs 
by second derivative spectrophotometry. 
compounds compound wavelength slope intercept correlation conc 
presents determined (nm) (lO"^) (10.3) coefficient range 
(ppm) 
TC & . T C ^ 21?^ O ^ 2 - 6 4 
Novobiocin Novobiocin 314.4 35.15 11.33 1.0000 2 - 64 
TC & TC 1163 4569 2 - 64 
Amphotericin B Amphotericin B 247.5 3.731 12.44 0.9999 2 - 48 
TC & TC 3 6 5 l i l 3 0 T M o 2 - 6 4 
Ascorbic acid Ascorbic acid 248.2 47.07 8.245 1.0000 2 - 48 
CTC& ^ i ™ SM 3347 09^ 2-64 
Beclomethasone Beclomethasone 283.8 7.186 -0.913 1.0000 1 - 80 
Dipropionate dipropionate 
O T C & OTC mA 3l9S OSm 2 - 4 8 
polymyxin B Polymyxin B 224.2 12.67 -1.092 1.0000 1 - 120 
OTC& O T C ^ l a ^ K9m 2 - 4 8 
lidocaine lidocaine 247.4 6.961 0.821 1.0000 1 - 160 
TC & TC I H S ：！^ 2 - 6 4 
CTC CTC 225.8 10.1 -0.231 0.9998 2 - 64 
TC & TC 3 7 ^ 0 0 5 2 - 64 
DTC DTC 380.2 2.635 -3.635 0.9998 2 - 48 
CTC & ^ 24^ i j ^ 2 - 64 
OTC OTC 235.3 21.22 1.366 0.9999 2 - 48 
C T C & ^ ^ ：0313 2 - 6 4 
DTC DTC 235.6 23.99 2.266 0.9999 2 - 48 
DTC & DTC 1900 o l ^ 0 9 ^ 2 - 4 8 
OTC OTC 375.2 3.075 3.283 0.9997 2 - 48 
"rc TC l l 3 0 LOOOO 2 - 64 
^ ^ ^ TSU 2-64 
DTC DTC SIOS I m LOOOO 2 - 4 8 
OTC OTC M a I m 0 9 9 ^ 2 - 4 8 
MTC MTC 36L0 s H o LI99 0 9 ^ 2 - 64 
8 1 
3.3.8 Results for the determination of TC, CTC, DTC, OTC, MTC and 
related drugs in pharmaceutical preparations 
The content of TCs and related drugs in tablets, capsules or ointments was 
determined by the second derivative spectrophotometric method. The results 
are summarised in Table 18 and the results obtained by the established HPLC 
method are also included for comparison. Table 19 shows statistical 
comparison of the results obtained by the proposed method and the HPLC 
method. Each determination was repeated five times. 
The results of the determination of TCs and related drugs in tablets, 
capsules or ointments show that there is a close agreement among result 
obtained by the proposed method, HPLC method and the nominal 
compositions, indicating the accuracy of the proposed method. In fact，the 
assay method using HPLC has higher detection limit and more time-
consuming. The proposed method requires only simple dissolution of the 
sample in the solvent. Thus the proposed method is much simpler and more 
rapid. 
3.4 Conclusion 
The secondary derivative spectrophotometry has been tested successfully 
for quantitative determination of various tetracyclines and their related drugs. 
The method is accurate, precise, simple, rapid and suitable for routine 
analysis of all commonly used tetracyclines in pharmaceutical preparations. 
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Table 18. Results of A l l Drugs Investigated by the Proposed Method and the 
HPLC Method. 
Drug 一 “ ‘ ‘ 
proprietary Nominal Compound Proposed Method 
name and Form Composition Determined Found Error % HPLC method Supplier 
Albamycin T Capsule TCHCl 125mg TCHCl 128mg 2.4 
(upjoin) Novobiocin 125mg Novobiocin 126mg 0:8 -
Talsutin Tablet TCHCl lOOmg TCHCl 103 mg 3 
(squibb) Amphotericin B Amphotericin B 52.1mg 4.2 -
50mg , 
Propaderm-A Ointment CTCHCl 3 % CTCHCl 3.12% 4 
(Glaxo) Beclomethasone Beclomethasone 0.023% -8.0 -
Dipropionate dipropionate 
0.025% 
Terramycin Ophthalmic Per g: OTCHCl 5.13mg 2.6 
with Ointment OTCHCl 5mg 
Polymyxin B polymyxin B Img Polymyxin B 1.04mg 4.0 . 
Sevitet Capsule TCHCl 250mg T O r a 2 4 7 ^ 2 4 W 
(Servipharm) " 
Achromycin V Capsule TCHCl 250mg TCHCl 2541^ H B w 
(Lederle) ^ 
Aureomycin Capsule CTCHCl 250mg CTCHCl 25^ 18 25W 
(Lederle) ^ 
Aureomycin Ointment CTC 3% CTT Ii4% J j 22% 
(Lederle) . . 
Aureomycin Ophthalmic CTCHC 1% CTCHCl O ^ 1, o ^ 
(Lederle) Ointment • 
Chlortralcin Opthalmic CTCHCl 1% CTCHCl 09^ ：4 103% 
(Atlantic • 
Lab.) 
Terramycin Capsule ~OTC 250mg OTC 246i^  Ts 
(Pfizer) ® 
Vibramycin tablet DTCHCl lOOmg DTCHCl 104^ 40 10^ 
(Pfizer) ^ 
Vibramycin Capsule DTCHCl lOOmg D T C H C l l O W lo IQW 
(Pfizer) b 
Bronmycin Capsule DTCHCl lOOmg DTCHCl lOW 30 i ow “ 
(Biolab) b 
Minocin Capsule MTCHCl 50mg MTCHCl 51.0mg lo ： 
(Lederic) 
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Table 19. Statistical comparison of the results obtained by the proposed 
method and the HPLC method. 
Drug 一 proprietary Compound Recovery 土 standard deviation,% name and Form Determined proposed method HPLC method 
Supplier 
Albamycin T C a p s u l e TCHCl 102.4 ±0.6 I 
(upjoin) Novobiocin 100.8 ±0.7 -
Talsutin Tablet TCHCl 103.0 ±0.2 ： 
(squibb) Amphotericin B 104.2 ±0.4 -
Propaderm-A Ointment CTCHCl 104.0 ±0.3 I 
(Glaxo) Beclomethasone 92.0 ±0.6 -
dipropionate 
Terramycin Ophthalmic OTCHCl 102.6 ±0.4 -
with Ointment 
Polymyxin B Polymyxin B 104.0 ±0.8 -
Sevitet Capsule TCHCl 98.8 ±0.2 99.2 ±0.5 
(Servipharm) 
Achromycin V Capsule TCHCl 101.6 ±0.4 102.0 ±0.2 
(Lederle) 
Aureomyc inCapsu l e CTCHCl 102.8 ±0.2 101.2 ±0.5 
(Lederle) 
Aureomyc inOin tmen t CTC 104.7 ±0.4 106.7 ±0.8 
(Lederle) 
AureomycinOptha lmic CTCHCl 94.0 ±0.5 96.0 ±0.7 
(Lederle) Ointment 
Chlortralcin Opthalmic CTCHCl 96.0 ±0.5 103.0 ±0.4 
(Atlantic 
Lab.) 
Terramycin Capsule OTC 98.4 ±0.7 98.5 ±0.3 
(Pfizer) 
Vibramycin tablet DTCHCl 104.0 ±0.4 102.0±0 6 
(Pfizer) • 
Vibramycin Capsule DTCHCl 102.0 ±0.2 105.0 ±0.6 
(Pfizer) 
Bronmycin Capsule DTCHCl 103.0 ±0.4 104.0 ±0.7 
(Biolab) 
Minocin Capsule MTCHCl 104.0 ±0.5 -
(Lederic) 
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In addition, simultaneous determination of binary mixture of TCs and its co-
exist drugs can be performed. The proposed method is selective. There is 
no interference from most compounds added to the drug formulation 
containing tetracyclines. 
The method is applicable to a wide range of samples. The working range 
of the method is wide and can cover the normal concentration range of TCs 
present in various types of sample. Furthermore, some types of tetracyclines 
are suitable for veterinary uses. The proposed method is also applicable to 
the analysis of TCs in the feed after a fi l tration process. 
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